Hypera (OTCMKTS:HYPMY) Releases Quarterly Earnings Results

Hypera (OTCMKTS:HYPMY) released its quarterly earnings data on Thursday. The company reported $0.02 earnings per share (EPS) for the quarter, Zacks reports. Hypera had a return on equity of 13.18% and a net margin of 20.04%. The firm had revenue of $258.56 million during the quarter.

Hypera Trading Up 4.7 %

Shares of OTCMKTS HYPMY opened at $3.62 on Friday. The business has a 50 day simple moving average of $3.27 and a 200 day simple moving average of $3.74. Hypera has a 52 week low of $2.64 and a 52 week high of $6.90. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41.

About Hypera

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.